This dual strategy—developing serum-free media and engineering immortalized cell lines—addresses two of the most pressing challenges in cultured meat production: cost reduction and stable scalability.

The US has recently launched a new battery production line, which is expected to ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Formation of an immunological synapse (gray) between CAR-T cells, which are specially equipped to express the CCR7 receptor(cyan), and tumor cells (magenta). The CAR ...

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide and an increasing number of potential hPSC-derived clinical products have ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...

Michel Sadelain, a global pioneer in CAR T-cell immunotherapy, will head the new Columbia Initiative in Cell Engineering and Therapy. Interim University President Katrina Armstrong announced the ...

Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the ...

A team of scientists in China has developed a targeted passivation technique that significantly ...